Detalles de la búsqueda
1.
Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia.
Hematol Transfus Cell Ther
; 45(3): 338-341, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35882618
2.
Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability.
Oncotarget
; 14: 977-994, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085126
3.
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy.
Hematol Transfus Cell Ther
; 44(2): 206-212, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35071990
4.
Association of preoperative anemia and increased risk of blood transfusion and length of hospital stay in adults undergoing hip and knee arthroplasty: An observational study in a single tertiary center.
Health Sci Rep
; 4(4): e448, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34938895
5.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.
Hematol Transfus Cell Ther
; 42(3): 200-205, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32405620
6.
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.
Hematol Transfus Cell Ther
; 42(2): 103-110, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32313873
7.
The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest.
Hematol Transfus Cell Ther
; 46(3): 219-220, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821779
8.
BCL-2 as therapeutic target for hematological malignancies.
J Hematol Oncol
; 11(1): 65, 2018 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747654
9.
Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia
Hematol., Transfus. Cell Ther. (Impr.)
; 45(3): 338-341, July-Sept. 2023. tab
Artículo
en Inglés
|
LILACS-Express
| ID: biblio-1514171
10.
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy
Hematol., Transfus. Cell Ther. (Impr.)
; 44(2): 206-212, Apr.-June 2022. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-1385048
11.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Hematol Transfus Cell Ther
; 44(3): 410-418, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970751
12.
Evaluation of miR-15a, miR-16-1, ZAP-70, Ang-2, and Bcl-2 as potential prognostic biomarkers in chronic lymphocytic leukemia
Braz. J. Pharm. Sci. (Online)
; 58: e19332, 2022. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-1384002
13.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe
Hematol., Transfus. Cell Ther. (Impr.)
; 42(3): 200-205, July-Sept. 2020.
Artículo
en Inglés
| LILACS | ID: biblio-1134043
14.
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
Hematol., Transfus. Cell Ther. (Impr.)
; 42(2): 103-110, Apr.-June 2020. ilus
Artículo
en Inglés
| LILACS | ID: biblio-1134022
15.
Custo-efetividade do esquema com daratumumabe, bortezomibe e dexametasona em comparação com terapias à base de carfilzomibe, elotuzumabe e ixazomibe para o tratamento de mieloma múltiplo recidivado e refratário na perspectiva de um pagador do sistema de saúde suplementar brasileiro / Cost-effectiveness analysis of daratumumab, bortezomib, and dexamethasone combination in comparison to carfilzomib, elotuzumab and ixazomib-based therapies for the treatment of patients with relapsed and refractory multiple myeloma from a Brazilian private payer perspective
J. bras. econ. saúde (Impr.)
; 10(2): 148-156, Agosto/2018.
Artículo
en Portugués
| LILACS, ECOS | ID: biblio-915096
16.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associac ao Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I
Hematol., Transfus. Cell Ther. (Impr.)
; 44(3): 410-418, July-Sept. 2022.
Artículo
en Inglés
| LILACS | ID: biblio-1405010
Resultados
1 -
16
de 16
1
Próxima >
>>